Neuro Spectrum Insights' IPO

Q: When is Neuro Spectrum Insights' IPO?

3,750,000 shares at $4 to $5 (amended S-1 of Oct 5, 2026). No day set yet.

Q: How many shares is Neuro Spectrum Insights selling?

3,750,000 shares, per its amended S-1.

Q: When does the lock-up end?

Its prospectus sets a lock-up of 180 days; the day it ends is read from its final prospectus once it lists.

3,750,000 shares at $4 to $5 (amended S-⁠1 of Oct 5, 2026). No day set yet.

Range

$4 to $5

Market cap

$67.9M

3,750,000

Breakaway does the work for you: insider and Congress trades, the chart, and the financials, in one score.

Once Neuro Spectrum Insights lists, Breakaway scores it against every US stock

Its Quality Score from its second session, ranked against 3,191 stocks
Every insider trade, the day it is filed
The lock-up's end on your calendar, once the prospectus dates it
An alert when its score is first set, and when it turns

Get an alert the day NSIH lists

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

From its amended S-1 on SEC EDGAR, filed Oct 5, 2026.

What does Neuro Spectrum Insights do?

“We are a medical device company preparing to commercialize breakthrough computerized analysis technology that enhances clinicians' capabilities in diagnosing neurological and neurodevelopmental disorders.”

From its amended S-1, filed Oct 5, 2026

Neuro Spectrum Insights' facts, each with its source
Fact	Neuro Spectrum Insights
Incorporated	Delaware, 2016From its amended S-1 of Oct 5, 2026
Headquarters	Bedminster, New JerseyFrom its amended S-1 of Oct 5, 2026
Website	neurospectruminsights.comFrom its amended S-1 of Oct 5, 2026

What is the offering?

Each figure names the filing it is from and that filing's date. The market cap is Breakaway's arithmetic from the prospectus's share count.

Neuro Spectrum Insights' facts, each with its source
Fact	Neuro Spectrum Insights
Shares offered	3,750,000From the amended S-1 filed Oct 5, 2026
Price range	$4 to $5 a shareFrom the amended S-1 filed Oct 5, 2026
Underwriters	NETWORK 1 FINANCIAL SECURITIES and ALEXANDER CAPITALFrom the amended S-1 filed Oct 5, 2026, as its cover names them
Exchange	NYSE American, as NSIH (applied to list)From the amended S-1 filed Oct 5, 2026
Shares outstanding after	15,087,815From the amended S-1 filed Oct 5, 2026
Market cap at the midpoint	$67.9 millionBreakaway's arithmetic from the prospectus's share count

What the filing says about its money

Neuro Spectrum Insights' facts, each with its source
Fact	Neuro Spectrum Insights
Revenue	None from product sales yetFrom its amended S-1 of Oct 5, 2026: it has not generated any revenue
Net loss	$1.8 million, year to December 31, 2025From its amended S-1 of Oct 5, 2026, its summary financial data
Raised before the IPO	$458,000 in private financingsFrom its amended S-1 of Oct 5, 2026

What risks does Neuro Spectrum Insights name first?

“Even if this offering is successful, we may need additional funding in order to grow our business.”
“The commercial success of our technology and our revenue growth depends upon attaining significant market acceptance among payers, providers, clinics, and patients.”
“Our operating results may fluctuate significantly, which makes our future operating results difficult to predict and could cause our operating results to fall below expectations on any guidance we may provide.”

The first three of the risks its prospectus summary lists, in the company's words. The rest, and each in full, are in the filing. Read the filing.

Every date of Neuro Spectrum Insights' IPO

Neuro Spectrum Insights' IPO dates, each with its source
What	Day	Source
Registration filedForm S-1, SEC EDGAR	Jun 20, 2025	Form S-1, SEC EDGAR
Price range setamended S-1, SEC EDGAR	Oct 5, 2026	amended S-1, SEC EDGAR
Lock-upPer its amended S-1; the day comes once it lists	180 days	Per its amended S-1; the day comes once it lists

The other IPOs expected

The other IPOs expected or in registration
Company	Price	Market cap	Expected
OPAYNYSE: OPAY · No day yet	$19 to $21	Not yet	No day yetexchange registration Oct 26
Georgia BankingNasdaq: GBC · No day yet	Direct	Not yet	No day yetexchange registration Oct 21
Aspen NeuroscienceNasdaq: ASPE · No day yet	$15 to $17About $465M	$465Mat the midpoint	No day yetterms set Oct 26
Bambusa TherapeuticsNasdaq: BBTX · No day yet	$15 to $17About $796M	$796Mat the midpoint	No day yetterms set Oct 26
BitariNasdaq: BIAI · No day yet	$7About $302M	$302Mat the midpoint	No day yetterms set Oct 26
LIS TechnologiesNasdaq · No day yet	$5 to $7	Not yet	No day yetterms set Oct 26

Neuro Spectrum Insights IPO questions

When is Neuro Spectrum Insights' IPO?

3,750,000 shares at $4 to $5 (amended S-⁠1 of Oct 5, 2026). No day set yet.

What is Neuro Spectrum Insights' IPO price?

Neuro Spectrum Insights set a range of $4 to $5 a share in its amended S-⁠1 of Oct 5, 2026. The final price is set the evening before it lists.

How many shares is Neuro Spectrum Insights selling?

3,750,000 shares, per its amended S-⁠1.

Who are the underwriters?

NETWORK 1 FINANCIAL SECURITIES and ALEXANDER CAPITAL, as the prospectus's cover names them.

When does the lock-up end?

Its prospectus sets a lock-⁠up of 180 days; the day it ends is read from its final prospectus once it lists.

Does Breakaway rate Neuro Spectrum Insights?

Breakaway scores a new stock from its second trading day, ranked against every US stock it scores. For its first 21 sessions the page says New listing in place of the tier, and each check that needs more history waits for it.

Can Breakaway say where Neuro Spectrum Insights' price will go?

No. Breakaway does not say where a price will go. Every figure here is from the company's SEC filings, linked on each line.

Where every figure comes from.

Each company's SEC filings on EDGAR, read twice a day: its registration (Form S-1 or F-1), the amendment that sets its price range, and its final prospectus (424B4). The shares, the price, the underwriters, the lock-up, and the company's words are the filing's, linked on each line.
The expected day is Massive's IPO calendar's, the first trade the market data's, and the moves each stock's daily closes against its offer price.
The market cap is Breakaway's arithmetic: the shares the prospectus says will be outstanding after the offering, times the midpoint of the range or the offer price.
The Quality Score is Breakaway's, from a stock's second trading day; for its first 21 sessions it is marked New listing, and each check that needs more history waits for it.
Blank-check companies (SPACs) and unit offerings are left out and counted; a direct listing and a US listing of a company listed abroad are in and marked.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Once Neuro Spectrum Insights lists, Breakaway scores it against every US stock

Its Quality Score from its second session, ranked against 3,191 stocks
Every insider trade, the day it is filed
The lock-up's end on your calendar, once the prospectus dates it
An alert when its score is first set, and when it turns

Get an alert the day NSIH lists

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Every IPO expected and listed.